173 related articles for article (PubMed ID: 3003415)
1. Primary therapy for Cushing's disease with metyrapone.
Dickstein G; Lahav M; Shen-Orr Z; Edoute Y; Barzilai D
JAMA; 1986 Mar; 255(9):1167-9. PubMed ID: 3003415
[TBL] [Abstract][Full Text] [Related]
2. Short and long-term responses to metyrapone in the medical management of 91 patients with Cushing's syndrome.
Verhelst JA; Trainer PJ; Howlett TA; Perry L; Rees LH; Grossman AB; Wass JA; Besser GM
Clin Endocrinol (Oxf); 1991 Aug; 35(2):169-78. PubMed ID: 1657460
[TBL] [Abstract][Full Text] [Related]
3. Successful control of Cushing's disease in the elderly with long term metyrapone.
Donckier J; Burrin JM; Ramsay ID; Joplin GF
Postgrad Med J; 1986 Aug; 62(730):727-30. PubMed ID: 3022270
[TBL] [Abstract][Full Text] [Related]
4. Drug controlled of Cushing's syndrome. Combined aminoglutethimide and metyrapone therapy.
Child DF; Burke CW; Burley DM; Rees LH; Fraser TR
Acta Endocrinol (Copenh); 1976 Jun; 82(2):330-41. PubMed ID: 179256
[TBL] [Abstract][Full Text] [Related]
5. Postoperative metyrapone test in the early assessment of outcome of pituitary surgery for Cushing's disease.
van Aken MO; de Herder WW; van der Lely AJ; de Jong FH; Lamberts SW
Clin Endocrinol (Oxf); 1997 Aug; 47(2):145-9. PubMed ID: 9302385
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of Metyrapone in Treating Cushing's Syndrome: A Retrospective Multicenter Study in 195 Patients.
Daniel E; Aylwin S; Mustafa O; Ball S; Munir A; Boelaert K; Chortis V; Cuthbertson DJ; Daousi C; Rajeev SP; Davis J; Cheer K; Drake W; Gunganah K; Grossman A; Gurnell M; Powlson AS; Karavitaki N; Huguet I; Kearney T; Mohit K; Meeran K; Hill N; Rees A; Lansdown AJ; Trainer PJ; Minder AE; Newell-Price J
J Clin Endocrinol Metab; 2015 Nov; 100(11):4146-54. PubMed ID: 26353009
[TBL] [Abstract][Full Text] [Related]
7. Mitotane, metyrapone, and ketoconazole combination therapy as an alternative to rescue adrenalectomy for severe ACTH-dependent Cushing's syndrome.
Kamenický P; Droumaguet C; Salenave S; Blanchard A; Jublanc C; Gautier JF; Brailly-Tabard S; Leboulleux S; Schlumberger M; Baudin E; Chanson P; Young J
J Clin Endocrinol Metab; 2011 Sep; 96(9):2796-804. PubMed ID: 21752886
[TBL] [Abstract][Full Text] [Related]
8. ACTH-independent Cushing's syndrome in pregnancy with spontaneous resolution after delivery: control of the hypercortisolism with metyrapone.
Close CF; Mann MC; Watts JF; Taylor KG
Clin Endocrinol (Oxf); 1993 Sep; 39(3):375-9. PubMed ID: 8222300
[TBL] [Abstract][Full Text] [Related]
9. Recurrent ACTH-independent Cushing's syndrome in multiple pregnancies and its treatment with metyrapone.
Hána V; Dokoupilová M; Marek J; Plavka R
Clin Endocrinol (Oxf); 2001 Feb; 54(2):277-81. PubMed ID: 11207645
[TBL] [Abstract][Full Text] [Related]
10. Effect of metyrapone pretreatment on adrenocorticotropin secretion induced by corticotropin-releasing hormone in normal subjects and patients with Cushing's disease.
Totani Y; Niinomi M; Takatsuki K; Oiso Y; Tomita A
J Clin Endocrinol Metab; 1990 Mar; 70(3):798-803. PubMed ID: 2155255
[TBL] [Abstract][Full Text] [Related]
11. Drugs in the medical treatment of Cushing's syndrome.
Schteingart DE
Expert Opin Emerg Drugs; 2009 Dec; 14(4):661-71. PubMed ID: 19939210
[TBL] [Abstract][Full Text] [Related]
12. [Adrenostatic treatment of ACTH-dependent Cushing syndrome using metyrapone and aminoglutethimide].
Reincke M; Allolio B; Jaursch-Hancke C; Kaulen D; Winkelmann W
Dtsch Med Wochenschr; 1987 Oct; 112(40):1532-5. PubMed ID: 2820688
[TBL] [Abstract][Full Text] [Related]
13. Aminoglutethimide and metyrapone in the management of Cushing's syndrome.
Thorén M; Adamson U; Sjöberg HE
Acta Endocrinol (Copenh); 1985 Aug; 109(4):451-7. PubMed ID: 3898689
[TBL] [Abstract][Full Text] [Related]
14. Variable hormonogenesis in Cushing's syndrome.
Shapiro MS; Shenkman L
Q J Med; 1991 Apr; 79(288):351-63. PubMed ID: 1649480
[TBL] [Abstract][Full Text] [Related]
15. Prolonged remission in florid Cushing's syndrome following metyrapone treatment.
Beardwell CG; Adamson AR; Shalet SM
Clin Endocrinol (Oxf); 1981 May; 14(5):485-92. PubMed ID: 6273022
[TBL] [Abstract][Full Text] [Related]
16. Metyrapone for Cushing's syndrome.
Inagaki M; Akizuki N; Kugaya A; Fujii H; Akechi T; Uchitomi Y
Am J Psychiatry; 2002 Jul; 159(7):1246. PubMed ID: 12091216
[No Abstract] [Full Text] [Related]
17. The combined use of sodium valproate and metyrapone in the treatment of Cushing's syndrome.
Nussey SS; Price P; Jenkins JS; Altaher AR; Gillham B; Jones MT
Clin Endocrinol (Oxf); 1988 Apr; 28(4):373-80. PubMed ID: 2847889
[TBL] [Abstract][Full Text] [Related]
18. Plasma corticotropin and cortisol responses to ovine corticotropin-releasing hormone (CRH), arginine vasopressin (AVP), CRH plus AVP, and CRH plus metyrapone in patients with Cushing's disease.
Dickstein G; DeBold CR; Gaitan D; DeCherney GS; Jackson RV; Sheldon WR; Nicholson WE; Orth DN
J Clin Endocrinol Metab; 1996 Aug; 81(8):2934-41. PubMed ID: 8768855
[TBL] [Abstract][Full Text] [Related]
19. Cyproheptadine in the control of Cushing's disease.
Hsu TH; Gann DS; Tsan KW; Russell RP
Johns Hopkins Med J; 1981 Aug; 149(2):77-83. PubMed ID: 6265685
[TBL] [Abstract][Full Text] [Related]
20. Twelve-hour cycles of adrenocorticotropin and cortisol secretion in Cushing's disease.
Schteingart DE; McKenzie AK
J Clin Endocrinol Metab; 1980 Nov; 51(5):1195-8. PubMed ID: 6252234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]